valrubicinpembrolizumabnadofaragene firadenovecDurvalumaberdafitinib
…ducted, no agents have received approval, with the exception of valrubicin, largely attributed to factors such as the varied prior BCG exp…
1articles mentioning drugs
16drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: nadofaragene firadenovec ×
nadofaragene firadenovec
This drug is selected. Its supporting articles are shown below.